Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zai Lab Limited - American Depositary Shares
(NQ:
ZLAB
)
20.41
+0.44 (+2.20%)
Official Closing Price
Updated: 1:15 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
211,500
Open
20.39
Bid (Size)
20.00 (3,000)
Ask (Size)
20.41 (100)
Prev. Close
19.97
Today's Range
19.98 - 20.46
52wk Range
19.51 - 44.34
Shares Outstanding
956,637,360
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Nuvation Bio (NUVB) Soars on IBTROZI's Blockbuster Launch and Stellar Q3 2025 Performance
November 19, 2025
Boston, MA – November 19, 2025 – Nuvation Bio Inc. (NASDAQ: NUVB) has captured the financial spotlight, witnessing a remarkable 47.71% surge in its stock price following a stellar third-quarter 2025...
Via
MarketMinute
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
November 06, 2025
From
Zai Lab Limited
Via
Business Wire
Performance
YTD
-17.7%
-17.7%
1 Month
-20.0%
-20.0%
3 Month
-38.8%
-38.8%
6 Month
-34.6%
-34.6%
1 Year
-29.3%
-29.3%
More News
Read More
Earnings Scheduled For November 6, 2025
↗
November 06, 2025
Via
Benzinga
Zai Lab Announces Participation in Investor Conferences in November and December 2025
October 31, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab To Await More Trial Data Before Filing For Regulatory Approval For Experimental Cancer Drug
↗
September 03, 2025
Via
Stocktwits
Earnings Scheduled For August 7, 2025
↗
August 07, 2025
Via
Benzinga
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study
October 24, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025
October 15, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
October 13, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab's Double Whammy: Earnings Miss, Phase 3 Setback
↗
September 11, 2025
Via
Benzinga
Topics
Earnings
China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order
↗
September 10, 2025
Via
Investor's Business Daily
Topics
Government
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zai Lab Limited - ZLAB
September 06, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Amgen Faces Setback As Final Data Weakens Case For Gastric Cancer Drug
↗
September 04, 2025
Via
Benzinga
C3.ai Posts Downbeat Results, Joins GitLab, Salesforce And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
September 04, 2025
Via
Benzinga
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
September 01, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Participation in Investor Conferences in September 2025
August 28, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer
August 19, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab Establishes Oncology Scientific Advisory Board
August 13, 2025
From
Zai Lab Limited
Via
Business Wire
Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates
August 07, 2025
From
Zai Lab Limited
Via
Business Wire
Netflix, BlackSky Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
↗
July 18, 2025
Via
Benzinga
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025
July 10, 2025
From
Zai Lab Limited
Via
Business Wire
Amgen's Gastric Cancer Drug Improves Survival In Phase 3, Notes Ocular Side Effects
↗
June 30, 2025
Via
Benzinga
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer
June 30, 2025
From
Zai Lab Limited
Via
Business Wire
ZAI LAB LTD-ADR (NASDAQ:ZLAB) – A High-Growth Biotech Stock Meeting Minervini’s Criteria
↗
June 16, 2025
Via
Chartmill
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025
June 13, 2025
From
Zai Lab Limited
Via
Business Wire
Frequently Asked Questions
Is Zai Lab Limited - American Depositary Shares publicly traded?
Yes, Zai Lab Limited - American Depositary Shares is publicly traded.
What exchange does Zai Lab Limited - American Depositary Shares trade on?
Zai Lab Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Zai Lab Limited - American Depositary Shares?
The ticker symbol for Zai Lab Limited - American Depositary Shares is ZLAB on the Nasdaq Stock Market
What is the current price of Zai Lab Limited - American Depositary Shares?
The current price of Zai Lab Limited - American Depositary Shares is 20.41
When was Zai Lab Limited - American Depositary Shares last traded?
The last trade of Zai Lab Limited - American Depositary Shares was at 11/28/25 01:15 PM ET
What is the market capitalization of Zai Lab Limited - American Depositary Shares?
The market capitalization of Zai Lab Limited - American Depositary Shares is 19.52B
How many shares of Zai Lab Limited - American Depositary Shares are outstanding?
Zai Lab Limited - American Depositary Shares has 20B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
